4.51
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Serina secures additional $5 million for Parkinson's trial - MSN
Serina secures additional $5 million for Parkinson's trial By Investing.com - Investing.com Australia
Stocks to Watch: Palantir Technologies, Synaptics, J&J Snack Foods, Serina Therapeutics - MarketWatch
Serina Therapeutics's Shares Up Following $5M of Equity Financing - MarketWatch
Serina Therapeutics Receives Second $5 Mln Tranche To Strengthen Cash Position - Marketscreener.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Serina Therapeutics receives funding to advance SER-252 into clinical trial - TipRanks
Serina Therapeutics Secures $5 Million for SER-252 Trials - TipRanks
Serina Therapeutics Receives Second $5 Million Tranche to - GlobeNewswire
Parkinson's Breakthrough: Serina Therapeutics Lands Premium-Priced $5M Investment to Advance Novel Treatment - StockTitan
Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics - MarketWatch
Serina Therapeutics Shares Rise After Sale of UniverXome Subsidiary - MarketWatch
Serina Therapeutics Sells UniverXome Subsidiary - MarketWatch
Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewswire
Serina Therapeutics Achieves Debt-Free Status After $11.2M UniverXome Sale, Sharpens Focus on Parkinson's Drug - StockTitan
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewswire
Serina Therapeutics, Inc. Appoints Karen J. Wilson to its Board of Directors -January 14, 2025 at 05:25 pm EST - Marketscreener.com
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 By Investing.com - Investing.com Australia
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 - Investing.com
Serina Therapeutics expands equity incentive plan By Investing.com - Investing.com Australia
Serina Therapeutics expands equity incentive plan - Investing.com India
Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - BioSpace
Serina Therapeutics to Present at Tribe Public’s Webinar - GlobeNewswire
Serina Therapeutics to Unveil Breakthrough Parkinson's Treatment Strategy in Upcoming Webinar - StockTitan
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewswire
Serina Therapeutics Unveils Breakthrough LNP Technology: Zero Immune Response in Key Testing - StockTitan
Serina raises $10M to develop SER-252 for advanced Parkinson’s - Parkinson's News Today
Serina Therapeutics Raises $10M in Financing - FinSMEs
Serina Therapeutics, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes - MSN
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Ex - Asianet Newsable
Serina Therapeutics Shares Rise After $10 Million in Financing - MarketWatch
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - The Manila Times
Serina Therapeutics secures $10M financing - TipRanks
Serina Therapeutics Secures $10 Million Financing to - GlobeNewswire
Serina Therapeutics Secures $10M Financing for Parkinson's Drug Trial at 120% Premium - StockTitan
Serina Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - The Manila Times
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewswire Inc.
TSX Composite Capped Index (TOOC) QuotePress Release - The Globe and Mail
Serina Therapeutics Inc trading resumes - TipRanks
AgeX Therapeutics stock hits 52-week low at $5.72 - Investing.com India
AgeX Therapeutics stock hits 52-week low at $5.72 By Investing.com - Investing.com Canada
Serina Therapeutics CDO Presents at Injectables Summit - TipRanks
Serina Therapeutics to Present at the 14th Annual Injectables Summit - GlobeNewswire
SLM initiated with a Buy at BofA - TipRanks
Serina Therapeutics director buys $6.9k in company stock By Investing.com - Investing.com Australia
Serina Therapeutics director buys $6.9k in company stock - Investing.com India
Capitalizzazione:
|
Volume (24 ore):